FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:USP15-PPM1H

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: USP15-PPM1H
FusionPDB ID: 97228
FusionGDB2.0 ID: 97228
HgeneTgene
Gene symbol

USP15

PPM1H

Gene ID

9958

57460

Gene nameubiquitin specific peptidase 15protein phosphatase, Mg2+/Mn2+ dependent 1H
SynonymsUNPH-2|UNPH4ARHCL1|NERPP-2C|URCC2
Cytomap

12q14.1

12q14.1-q14.2

Type of geneprotein-codingprotein-coding
Descriptionubiquitin carboxyl-terminal hydrolase 15deubiquitinating enzyme 15ubiquitin thioesterase 15ubiquitin thiolesterase 15ubiquitin-specific-processing protease 15protein phosphatase 1Hneurite extension-related protein phosphatase related to PP2Cprotein phosphatase 1H (PP2C domain containing)ras homolog gene family, member C like 1
Modification date2020031320200327
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000550632, ENST00000280377, 
ENST00000312635, ENST00000353364, 
ENST00000393654, 
ENST00000228705, 
ENST00000551214, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score23 X 14 X 12=386412 X 10 X 6=720
# samples 2611
** MAII scorelog2(26/3864*10)=-3.89351156580732
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(11/720*10)=-2.71049338280502
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: USP15 [Title/Abstract] AND PPM1H [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: USP15 [Title/Abstract] AND PPM1H [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PPM1H(63328272)-USP15(62687960), # samples:3
USP15(62696701)-PPM1H(63114069), # samples:1
Anticipated loss of major functional domain due to fusion event.USP15-PPM1H seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
USP15-PPM1H seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
USP15-PPM1H seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
USP15-PPM1H seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PPM1H-USP15 seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF.
PPM1H-USP15 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneUSP15

GO:0007179

transforming growth factor beta receptor signaling pathway

21947082

HgeneUSP15

GO:0016579

protein deubiquitination

16005295|22344298|27368102

HgeneUSP15

GO:0030509

BMP signaling pathway

21947082

HgeneUSP15

GO:0035520

monoubiquitinated protein deubiquitination

21947082|24399297

HgeneUSP15

GO:0035616

histone H2B conserved C-terminal lysine deubiquitination

24526689

HgeneUSP15

GO:1900246

positive regulation of RIG-I signaling pathway

24399297



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:63328272/chr12:62687960)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across USP15 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PPM1H (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000353364USP15chr1262696701+ENST00000228705PPM1Hchr1263114069-5523425771015312
ENST00000280377USP15chr1262696701+ENST00000228705PPM1Hchr1263114069-550440658996312
ENST00000393654USP15chr1262696701+ENST00000228705PPM1Hchr1263114069-54553579947312
ENST00000312635USP15chr1262696701+ENST00000228705PPM1Hchr1263114069-546436618956312

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000353364ENST00000228705USP15chr1262696701+PPM1Hchr1263114069-0.0001155480.9998845
ENST00000280377ENST00000228705USP15chr1262696701+PPM1Hchr1263114069-0.0001187490.99988127
ENST00000393654ENST00000228705USP15chr1262696701+PPM1Hchr1263114069-0.0001150530.99988496
ENST00000312635ENST00000228705USP15chr1262696701+PPM1Hchr1263114069-0.0001152810.9998847

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for USP15-PPM1H

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
USP15chr1262696701PPM1Hchr1263114069357116YTLMEGQEPIARKAFMQPHLLGNEFT
USP15chr1262696701PPM1Hchr1263114069366116YTLMEGQEPIARKAFMQPHLLGNEFT
USP15chr1262696701PPM1Hchr1263114069406116YTLMEGQEPIARKAFMQPHLLGNEFT
USP15chr1262696701PPM1Hchr1263114069425116YTLMEGQEPIARKAFMQPHLLGNEFT

Top

Potential FusionNeoAntigen Information of USP15-PPM1H in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
USP15-PPM1H_62696701_63114069.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
USP15-PPM1Hchr1262696701chr1263114069406HLA-B50:02QEPIARKA0.99310.7951614
USP15-PPM1Hchr1262696701chr1263114069406HLA-B08:01EPIARKAF0.99160.5139715
USP15-PPM1Hchr1262696701chr1263114069406HLA-B45:01QEPIARKA0.97520.9698614
USP15-PPM1Hchr1262696701chr1263114069406HLA-B52:01KAFMQPHL0.92160.97151220
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:16KAFMQPHLL0.99720.92471221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B58:01KAFMQPHLL0.99710.95191221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:17KAFMQPHLL0.9970.95871221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B58:02KAFMQPHLL0.9970.95971221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B57:01KAFMQPHLL0.99690.98471221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B57:03KAFMQPHLL0.99650.99251221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B44:03QEPIARKAF0.95760.9821615
USP15-PPM1Hchr1262696701chr1263114069406HLA-A30:08KAFMQPHLL0.95680.80051221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B18:01QEPIARKAF0.9190.9796615
USP15-PPM1Hchr1262696701chr1263114069406HLA-A32:13KAFMQPHLL0.91150.97031221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B14:01KAFMQPHLL0.87830.86331221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B14:02KAFMQPHLL0.87830.86331221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B48:01KAFMQPHLL0.85480.71551221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B48:01RKAFMQPHL0.73710.86291120
USP15-PPM1Hchr1262696701chr1263114069406HLA-B35:04EPIARKAFM0.70910.8963716
USP15-PPM1Hchr1262696701chr1263114069406HLA-B35:02EPIARKAFM0.70910.8963716
USP15-PPM1Hchr1262696701chr1263114069406HLA-B50:01GQEPIARKA0.54640.8392514
USP15-PPM1Hchr1262696701chr1263114069406HLA-B13:02KAFMQPHLL0.51430.8091221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B52:01KAFMQPHLL0.46560.98021221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B13:01KAFMQPHLL0.33540.99441221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B07:10RKAFMQPHL0.02810.60471120
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:07ARKAFMQPHL0.99950.80041020
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:01GQEPIARKAF0.9990.9563515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:03GQEPIARKAF0.97640.8947515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B48:01RKAFMQPHLL0.95340.89161121
USP15-PPM1Hchr1262696701chr1263114069406HLA-B13:01GQEPIARKAF0.88680.9824515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:04ARKAFMQPHLL0.99990.79551021
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:05ARKAFMQPHLL0.99990.88231021
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:02ARKAFMQPHLL0.99990.65751021
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:07ARKAFMQPHLL0.99980.92031021
USP15-PPM1Hchr1262696701chr1263114069406HLA-B45:01MEGQEPIARKA0.99880.9841314
USP15-PPM1Hchr1262696701chr1263114069406HLA-B42:02EPIARKAF0.99770.5097715
USP15-PPM1Hchr1262696701chr1263114069406HLA-C15:04KAFMQPHLL0.99980.85011221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:19KAFMQPHLL0.99950.98911221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C15:06KAFMQPHLL0.99950.92961221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:07KAFMQPHLL0.99950.9721221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:08KAFMQPHLL0.9990.9621221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C04:06KAFMQPHLL0.99450.97141221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:05KAFMQPHLL0.97490.9821221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:13KAFMQPHLL0.97410.97671221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:29KAFMQPHLL0.97240.9751221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:19KAFMQPHLL0.97070.86751221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:27KAFMQPHLL0.95990.97661221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:95KAFMQPHLL0.95410.84871221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B40:03QEPIARKAF0.94140.6075615
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:14KAFMQPHLL0.94060.9821221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C12:12KAFMQPHLL0.93540.97531221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C06:03KAFMQPHLL0.90910.9971221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C12:04KAFMQPHLL0.89870.9971221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C08:13KAFMQPHLL0.8790.98271221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C08:04KAFMQPHLL0.8790.98271221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C02:06KAFMQPHLL0.85560.96551221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C12:16KAFMQPHLL0.83340.98591221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B35:12EPIARKAFM0.70910.8963716
USP15-PPM1Hchr1262696701chr1263114069406HLA-C01:17KAFMQPHLL0.68280.97121221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C08:03KAFMQPHLL0.66320.99171221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B44:10QEPIARKAF0.6050.5188615
USP15-PPM1Hchr1262696701chr1263114069406HLA-B39:10EPIARKAFM0.47060.7802716
USP15-PPM1Hchr1262696701chr1263114069406HLA-B51:07KAFMQPHLL0.42030.94051221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C01:30KAFMQPHLL0.30870.97481221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B48:03RKAFMQPHL0.23180.59991120
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:05GQEPIARKAF0.80960.9585515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:14ARKAFMQPHLL0.99990.85561021
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:03ARKAFMQPHLL0.99180.89641021
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:05KAFMQPHL0.99750.96841220
USP15-PPM1Hchr1262696701chr1263114069406HLA-B08:18EPIARKAF0.99160.5139715
USP15-PPM1Hchr1262696701chr1263114069406HLA-C16:02KAFMQPHL0.99090.99331220
USP15-PPM1Hchr1262696701chr1263114069406HLA-C16:01KAFMQPHL0.97640.98431220
USP15-PPM1Hchr1262696701chr1263114069406HLA-B08:12EPIARKAF0.9550.7112715
USP15-PPM1Hchr1262696701chr1263114069406HLA-B18:07EPIARKAF0.82090.8527715
USP15-PPM1Hchr1262696701chr1263114069406HLA-C15:09KAFMQPHLL0.99980.85011221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C15:05KAFMQPHLL0.99940.94431221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C15:02KAFMQPHLL0.99940.87251221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:17KAFMQPHLL0.99910.98551221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:67KAFMQPHLL0.99880.98751221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:05KAFMQPHLL0.99840.96981221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:03KAFMQPHLL0.99830.99241221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:04KAFMQPHLL0.99830.99241221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B58:06KAFMQPHLL0.99740.90461221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:02KAFMQPHLL0.9970.98481221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B57:10KAFMQPHLL0.99690.98471221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:10ARKAFMQPH0.99470.9071019
USP15-PPM1Hchr1262696701chr1263114069406HLA-B57:04KAFMQPHLL0.99390.82021221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C04:04KAFMQPHLL0.98870.97221221
USP15-PPM1Hchr1262696701chr1263114069406HLA-A32:01KAFMQPHLL0.98850.96831221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C16:02KAFMQPHLL0.98640.99381221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:04KAFMQPHLL0.98620.98011221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C16:04KAFMQPHLL0.9850.99261221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C03:06KAFMQPHLL0.98050.99281221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:22KAFMQPHLL0.97940.90171221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C16:01KAFMQPHLL0.97260.98471221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:17KAFMQPHLL0.96740.9791221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C07:01KAFMQPHLL0.96380.84691221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C06:06KAFMQPHLL0.96020.99461221
USP15-PPM1Hchr1262696701chr1263114069406HLA-A30:01KAFMQPHLL0.95830.89181221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B44:07QEPIARKAF0.95760.9821615
USP15-PPM1Hchr1262696701chr1263114069406HLA-B44:26QEPIARKAF0.95760.9821615
USP15-PPM1Hchr1262696701chr1263114069406HLA-B44:13QEPIARKAF0.95760.9821615
USP15-PPM1Hchr1262696701chr1263114069406HLA-B39:02RKAFMQPHL0.95740.98641120
USP15-PPM1Hchr1262696701chr1263114069406HLA-C12:03KAFMQPHLL0.94030.99221221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C06:17KAFMQPHLL0.93550.99681221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C06:02KAFMQPHLL0.93550.99681221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B57:02KAFMQPHLL0.91950.9311221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B18:05QEPIARKAF0.9190.9796615
USP15-PPM1Hchr1262696701chr1263114069406HLA-B18:11QEPIARKAF0.91840.9808615
USP15-PPM1Hchr1262696701chr1263114069406HLA-B18:08QEPIARKAF0.89540.8723615
USP15-PPM1Hchr1262696701chr1263114069406HLA-B18:03QEPIARKAF0.88250.9776615
USP15-PPM1Hchr1262696701chr1263114069406HLA-C06:08KAFMQPHLL0.87460.99441221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C02:02KAFMQPHLL0.8640.9871221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C02:10KAFMQPHLL0.8640.9871221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B35:13KAFMQPHLL0.82270.95291221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:30KAFMQPHLL0.7930.94351221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C17:01KAFMQPHLL0.75740.97091221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C01:03KAFMQPHLL0.74010.97491221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B35:09EPIARKAFM0.70910.8963716
USP15-PPM1Hchr1262696701chr1263114069406HLA-C12:02KAFMQPHLL0.70530.98671221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C01:02KAFMQPHLL0.69090.96971221
USP15-PPM1Hchr1262696701chr1263114069406HLA-C08:01KAFMQPHLL0.66320.99171221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B39:02KAFMQPHLL0.61420.97061221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B08:12EPIARKAFM0.60780.6649716
USP15-PPM1Hchr1262696701chr1263114069406HLA-B67:01EPIARKAFM0.56350.5433716
USP15-PPM1Hchr1262696701chr1263114069406HLA-B50:04GQEPIARKA0.54640.8392514
USP15-PPM1Hchr1262696701chr1263114069406HLA-B50:05GQEPIARKA0.54640.8392514
USP15-PPM1Hchr1262696701chr1263114069406HLA-B07:13KAFMQPHLL0.48570.8921221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B40:21KAFMQPHLL0.26690.58261221
USP15-PPM1Hchr1262696701chr1263114069406HLA-B40:12RKAFMQPHL0.23180.59991120
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:68RKAFMQPHL0.09330.87121120
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:06ARKAFMQPHL0.99970.84581020
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:09ARKAFMQPHL0.99920.92491020
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:125GQEPIARKAF0.9990.9563515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:33GQEPIARKAF0.9990.9563515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:34GQEPIARKAF0.9990.9563515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:135GQEPIARKAF0.9990.9589515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:24GQEPIARKAF0.99890.9733515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:68GQEPIARKAF0.99750.7925515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:50GQEPIARKAF0.99720.9636515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:53GQEPIARKAF0.99630.9464515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:54GQEPIARKAF0.99440.9326515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:12GQEPIARKAF0.98390.9498515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B48:02GQEPIARKAF0.91930.9711515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B15:20GQEPIARKAF0.80020.974515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B35:28GQEPIARKAF0.79220.9771515
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:06ARKAFMQPHLL0.99990.83361021
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:08ARKAFMQPHLL0.99990.8071021
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:10ARKAFMQPHLL0.99990.88691021
USP15-PPM1Hchr1262696701chr1263114069406HLA-B27:09ARKAFMQPHLL0.99960.88171021

Top

Potential FusionNeoAntigen Information of USP15-PPM1H in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of USP15-PPM1H

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
7235QEPIARKAFMQPHLUSP15PPM1Hchr1262696701chr1263114069406

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of USP15-PPM1H

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B53:011A1O7235QEPIARKAFMQPHL-3.20963-4.24493
HLA-B51:011E287235QEPIARKAFMQPHL-4.71049-4.82389
HLA-B51:011E287235QEPIARKAFMQPHL-2.41218-3.44748
HLA-B57:032BVO7235QEPIARKAFMQPHL-1.15793-2.19323
HLA-A03:012XPG7235QEPIARKAFMQPHL-2.82905-3.86435
HLA-B14:023BVN7235QEPIARKAFMQPHL-6.01624-6.12964
HLA-B14:023BVN7235QEPIARKAFMQPHL-3.0101-4.0454
HLA-B44:033DX77235QEPIARKAFMQPHL0.0456146-0.989685
HLA-B52:013W397235QEPIARKAFMQPHL-5.58746-5.70086
HLA-B52:013W397235QEPIARKAFMQPHL-3.59213-4.62743
HLA-B18:014JQV7235QEPIARKAFMQPHL-3.3293-3.4427
HLA-B18:014JQV7235QEPIARKAFMQPHL-0.305763-1.34106
HLA-A11:014UQ27235QEPIARKAFMQPHL-8.33749-8.45089
HLA-A11:014UQ27235QEPIARKAFMQPHL-6.15985-7.19515
HLA-A24:025HGA7235QEPIARKAFMQPHL-5.17069-6.20599
HLA-A24:025HGA7235QEPIARKAFMQPHL-4.18377-4.29717
HLA-B57:015VUD7235QEPIARKAFMQPHL-1.89423-2.92953
HLA-B27:056PYJ7235QEPIARKAFMQPHL-2.66447-3.69977
HLA-B27:056PYJ7235QEPIARKAFMQPHL-2.44586-2.55926
HLA-B27:036PZ57235QEPIARKAFMQPHL-5.44487-5.55827
HLA-B27:036PZ57235QEPIARKAFMQPHL-3.87227-4.90757
HLA-B44:053DX87235QEPIARKAFMQPHL-5.01764-5.13104
HLA-B44:053DX87235QEPIARKAFMQPHL-2.6392-3.6745
HLA-B44:021M6O7235QEPIARKAFMQPHL-6.36013-6.47353
HLA-B44:021M6O7235QEPIARKAFMQPHL-4.88756-5.92286
HLA-B07:025EO07235QEPIARKAFMQPHL-4.6629-4.7763
HLA-B07:025EO07235QEPIARKAFMQPHL-4.00587-5.04117
HLA-A02:016TDR7235QEPIARKAFMQPHL-4.04667-4.16007
HLA-A02:016TDR7235QEPIARKAFMQPHL-1.46854-2.50384

Top

Vaccine Design for the FusionNeoAntigens of USP15-PPM1H

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
USP15-PPM1Hchr1262696701chr12631140691019ARKAFMQPHGCACGAAAGGCATTCATGCAGCCTCAC
USP15-PPM1Hchr1262696701chr12631140691020ARKAFMQPHLGCACGAAAGGCATTCATGCAGCCTCACTTG
USP15-PPM1Hchr1262696701chr12631140691021ARKAFMQPHLLGCACGAAAGGCATTCATGCAGCCTCACTTGCTG
USP15-PPM1Hchr1262696701chr12631140691120RKAFMQPHLCGAAAGGCATTCATGCAGCCTCACTTG
USP15-PPM1Hchr1262696701chr12631140691121RKAFMQPHLLCGAAAGGCATTCATGCAGCCTCACTTGCTG
USP15-PPM1Hchr1262696701chr12631140691220KAFMQPHLAAGGCATTCATGCAGCCTCACTTG
USP15-PPM1Hchr1262696701chr12631140691221KAFMQPHLLAAGGCATTCATGCAGCCTCACTTGCTG
USP15-PPM1Hchr1262696701chr1263114069314MEGQEPIARKAATGGAAGGTCAAGAGCCAATAGCACGAAAGGCA
USP15-PPM1Hchr1262696701chr1263114069514GQEPIARKAGGTCAAGAGCCAATAGCACGAAAGGCA
USP15-PPM1Hchr1262696701chr1263114069515GQEPIARKAFGGTCAAGAGCCAATAGCACGAAAGGCATTC
USP15-PPM1Hchr1262696701chr1263114069614QEPIARKACAAGAGCCAATAGCACGAAAGGCA
USP15-PPM1Hchr1262696701chr1263114069615QEPIARKAFCAAGAGCCAATAGCACGAAAGGCATTC
USP15-PPM1Hchr1262696701chr1263114069715EPIARKAFGAGCCAATAGCACGAAAGGCATTC
USP15-PPM1Hchr1262696701chr1263114069716EPIARKAFMGAGCCAATAGCACGAAAGGCATTCATG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of USP15-PPM1H

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
Non-CancerUSP15-PPM1Hchr1262696701ENST00000280377chr1263114069ENST00000228705ERR315444

Top

Potential target of CAR-T therapy development for USP15-PPM1H

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to USP15-PPM1H

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to USP15-PPM1H

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource